Allied Market Research

Hypertension Drug Market and Its Future Outlook During the Period of 2017–2023

Hypertension Drug Market Size is Set to Grow at a Remarkable Pace in the Coming Years.


Portland, OR -- (SBWIRE) -- 08/29/2017 -- Hypertension is a condition where the systolic blood pressure rises over 140 mmHg and diastolic blood pressure over 90 mmHg. The precise cause of hypertension is unknown; however, factors such as smoking, obesity, stress, excess sodium, old age, sleep apnea, certain hormonal conditions, kidney diseases, sedentary lifestyle, poor diet, lack of exercise, and drugs & alcohol contribute to the incidence of hypertension.

Access full summary at:

According to the Centers of Disease Control and Prevention (CDC), hypertension was the primary reason for death of more than 410,000 Americans in 2014. Hypertension is a long-term disease, and thus requires daily administration of antihypertensive drugs, which is anticipated to drive the hypertension drug market. In addition, R&D activities related to hypertension drugs is expected to present new opportunities during the forecast period. However, patent expiry of antihypertensive drugs, such as Benicar and Diovan, may hinder the market growth. Furthermore, stringent government regulations, adverse effects of these drugs, and high cost of healthcare leading to undiagnosed hypertension restrict the market.

Hypertension Drug Market Key Segments:

By Type
- Diuretics
- Beta Blockers
- Angiotensin-converting Enzyme (Ace) Inhibitors
- Alpha-beta Blockers
- Angiotensin II Receptor Blockers
- Aldosterone Antagonists
- Calcium Channel Blockers
- Renin Inhibitors
- Alpha Blockers
- Central-acting Agents
- Vasodilators
- Others

By Geography
- North America
o U.S.
o Canada
o Mexico

- Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe

- Asia-Pacific
o Japan
o China
o India
o Rest of Asia-Pacific

o Latin America
o Middle East
o Africa

List of players profiled in the report
- Actelion Ltd.
- Novartis AG
- Pfizer Inc.
- Johnson &Johnson Ltd.
- Sanofi SA
- Lupin Limited
- Merck & Co.
- AstraZeneca plc.
- Gilead Sciences Inc.
- GlaxoSmithKline plc

Request TOC and Sample Report:

About Allied Market Research
Allied Market Research is a Market Research Company which offers Syndicate & Custom Market Research Reports with Consulting Services.

Contact Us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220,
United States.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285